|
|
Volumn 5, Issue 3, 2009, Pages 119-125
|
|
Report on the AIDS Vaccine 2008 Conference
a
b
c
d
e
|
|
Author keywords
Cellular immunitys; Clinical trials; HIV AIDS; Humoral immunity; Vaccine
|
|
Indexed keywords
DNA VACCINE;
GAMMA INTERFERON;
GLYCOPROTEIN GP 120;
GLYCOPROTEIN GP 140;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INTERLEUKIN 2;
INTERLEUKIN 5;
LIPID ANTIBODY;
MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE;
MONOCLONAL ANTIBODY;
NEUTRALIZING ANTIBODY;
RANTES;
SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;
T CELL FACTOR PROTEIN;
UNCLASSIFIED DRUG;
ADJUVANT THERAPY;
ANTIBODY BLOOD LEVEL;
ANTIBODY RESPONSE;
ANTIGEN EXPRESSION;
CD8+ T LYMPHOCYTE;
CELL BASED GENE THERAPY;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONFERENCE PAPER;
CYTOKINE RELEASE;
DNA VECTOR;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
ELECTROPORATION;
GENE THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMORAL IMMUNITY;
INFECTION SENSITIVITY;
INNATE IMMUNITY;
LOW DRUG DOSE;
MONKEY DISEASE;
MONOTHERAPY;
MUCOSAL IMMUNITY;
NATURAL KILLER T CELL;
NONHUMAN;
REPEATED DRUG DOSE;
SYMPOSIUM;
VIRAL GENE DELIVERY SYSTEM;
VIRUS TRANSMISSION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS VACCINES;
HUMANS;
SOUTH AFRICA;
|
|
EID: 67549151411
PISSN: 15548600
EISSN: 15548619
Source Type: Journal
DOI: 10.4161/hv.5.3.7557 Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (6)
|
